SOURCE: Mirada Medical Limited

April 21, 2011 09:00 ET

Mirada Medical Workflows for Radiology and Radiation Oncology Collaboration on Show at New CIRT Symposium

Mirada Medical Limited ("Mirada" or "the Company")

OXFORD, UNITED KINGDOM and PHILADELPHIA, PA--(Marketwire - Apr 21, 2011) - Leaders in multidisciplinary cancer imaging software, Mirada Medical will be demonstrating imaging software for collaborative working at the first ever Cancer Imaging and Radiation Therapy Symposium (CIRTS) held at the Atlanta Marriot Marquis, Atlanta, April 29-30, 2011. This symposium is jointly sponsored by the American Society of Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA), both of which hold conferences attended annually by Mirada Medical.

"It's great to see the RSNA and ASTRO coming together in this symposium for multidisciplinary cancer staging and treatment," says Hugh Bettesworth, CEO of Mirada Medical. "We believe that the multidisciplinary approach needs to extend further and deeper into the tools and technology clinical specialists use for assessing and treating patients. Failure to capitalise on joint working because the tools are not developed with this style of collaboration in mind leads to less efficient and potentially less effective working practice. At Mirada, we have focused our software development on delivering specific imaging workflows for exactly this type of collaboration between radiology and radiation oncology."

Mirada's XD3 software for oncology can combine images from vendor neutral CT, MR, PET, PET/CT, PET-MR and SPECT scanners over multiple time points during a patient's care program, from which important decisions can be made regarding patient progress and the course of treatment. The ability to propagate ROIs across multiple images and timepoints is further enhanced with semi-automated tools for target definition. The combination of both anatomical and functional images, plus quantification-based ROI tools, gives the user more confidence when defining tumor margins vs. normal tissue for planning purposes.

Interconnectivity with treatment planning systems is also an important aspect of the collaborative workflow between radiology and radiation oncology. "The vendor neutral nature of our products means that they can be used with all the major treatment planning companies for transfer of image data and contours,"saysBettesworth, "and we are also constantly developing new technologies and workflows for closing the loop between diagnosis, treatment and follow-up assessment. The ability to adjust treatment plans based on new information from imaging at more frequent intervals could have a significant impact on patient outcomes. We are excited to have the opportunity to show our latest developments at CIRTS."

A new product for Mirada Medical, first showcased at the RSNA in November 2010, is Casemeeting, which was developed entirely for clinical specialist collaboration in oncology during tumor board meetings or chart rounds. Casemeeting, also to be demonstrated at the symposium, allows a patient case to be presented and reviewed in a holistic manner, taking inputs from all relevant disciplines and combining them into a simple yet information-rich presentation.

In addition to XD3 and Casemeeting, Mirada will also be showcasing new product development utilizing atlas technologies developed by Dr. S. Finkelstein at Moffitt Cancer Center at booth no. 104, April 29-30 during the Cancer Imaging and Radiation Therapy Symposium (CIRTS), Atlanta Marriot Marquis, Atlanta.

About Mirada Medical

Mirada Medical is an internationally recognized brand in advanced medical imaging. The company develops high value clinical software applications, which are used across diagnostic radiology, nuclear medicine, radiation oncology, tumor board and elsewhere.

Mirada specializes in simplifying technically complex image quantification, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention.

Mirada was originally spun out of the University of Oxford. The company's technologies are, to this day, developed by a team of dedicated engineers and world-renowned scientists working out of Oxford, England.

Mirada's products have been designed to ease the deployment of these powerful technologies into any hospital or imaging center workflow. Mirada's applications can be delivered using thin client or cloud based architectures, or licensed on a floating or per workstation basis.

Most recently, Mirada has focused on the development of disease specific solutions for use across departments working with patients to fight cancer. In particular, Mirada's powerful image registration technologies have been tuned to the needs of radiation oncology, and quantification technologies have been redefined to optimize support for standard protocols such as RECIST and PERCIST. In addition, powerful imaging solutions have been introduced to support better collaborative working, in particular in the context of a rich web-based viewer for referring physicians and a robust solution for presentation of images at tumor board.

Mirada Medical Exhibits at Cancer Imaging Radiation Therapy Symposium: http://hugin.info/143183/R/1508494/443307.pdf

Contact Information